Anthi Chalou presented her half-time review
Month: November 2025
On the 27th November 2025, Anthi Chalou presented her progress in her PhD studies in Malmö, Sweden.
This review marks the half-way point of completing her PhD studies, wherein she is exploring the mechanisms and cellular targets of immune checkpoint inhibition-elicited cardiovascular inflammation. By better understanding these mechanisms, new clinical strategies preserving the potent anti-tumor effects of immune checkpoint inhibition treatment while also mitigating negative cardiovascular effects may be developed.
the HZDR team at the Dresden Immunology Seminar
Month: November 2025
On the 13th November 2025, Anja Feldmann, from the HZDR team, presented her work focused on Development of Radioimmunotheranostics: Combination of therapy and diagnostic imaging
Tuesday Talk with Ilze Bot in Leiden
Month: November 2025
Breaking the Cycle of Hearth Attacks
Why do heart attacks and strokes remain a threat – even in patients receiving treatment? These life-threatening events are often caused by unstable plaques in the bood vessels, which can suddenly rapture. while cholesterol-lowering medication reduces the risk, it’s not always enough. A growing body of scientific evidence suggests that the immune system may hold the key to understanding – and preventing – these dangerous complications.
At the Tuesday Talk, Professor Ilze Bot has explored how certain immune cells play a role in atherosclerosis, and what new treatment strategies might help to reduce the risk of sudden cardiovascular events.
Second Annual Meeting in Sweden
ULEI hosted our 2nd Annual Meeting at the Grand Hotel Lund, Sweden, between the 9th and 10th of October 2025.
The meeting was a valuable opportunity for in-person discussions, sharing results, and planning future activities. An important part of the event was the roundtable discussion to assess results, upcoming tasks, risks, and mitigation strategies in R&D work packages.
Additionally, the ULEI team updated on the activities in the Cardiogenomics Portfolio, including the upcoming EIC Portfolio event on March 16-17, 2026, focused on networking and a Tech-to-Market event in Leiden organized by ULEI, and INN-ACTA shared information about the outreach to patient organisations. Importantly, the coordinator presented the management and coordination activities and provided details for the upcoming reporting period and review meeting.
The meeting strengthened our connections and commitment within the consortium to further knowledge and identify new biomarkers and therapeutic targets for atherosclerosis.
Thank you to all partners for dedication and contributions, and a special thanks to the organizer for facilitating the meeting and welcoming us to Lund.